The effect of meal composition on postprandial glucagon-like peptide-1 response in overweight/obese participants
© Franklin et al. 2015
Published: 21 September 2015
Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted in the intestine in response to food intake. GLP-1 may be responsible for nearly 50% of insulin secretion. Postprandial GLP-1 secretion may be impaired in overweight/obese (OW/O) individuals and in patients with type-2 diabetes (T2D). Meals high in protein (HP) or high in monounsaturated fat (HMF) may increase GLP-1 response. However, there are no studies directly comparing HP with HMF meals on postprandial GLP-1 response.
Twenty-four OW/O participants (male/female: 12/12; age: 38.7 ± 15.3 (mean ± standard deviation) years; BMI: 31.6 ± 4.0kg/m2) were studied. Participants consumed a HMF and a HP meal in a random order at least 4 days apart. The HMF meal contained 35.2% energy from fat and 20.7% from monounsaturated fat and the HP meal contained 31.9% energy from protein. Energy and carbohydrate content were similar across meals. Blood samples were collected in the fasting and postprandial (30, 60, 120, and 180 min) states and analyzed for GLP-1 (active and total), insulin, glucagon, C-peptide, and glucose. A mixed effects repeated measures analysis model was used to examine the effect of meal composition on the outcome variables.
There were statistically significant (p < 0.01) time and time by meal composition interaction effects on active GLP-1 (see figure). Also found were statistically significant (p < 0.01) time, meal composition, and time by meal composition interaction effects on total GLP-1, insulin, C-peptide, and glucagon. The responses were higher on the HP compared to the HMF meal (p < 0.05) for active and total GLP-1 and C-peptide at 120 and 180 min, insulin at 60, 120, and 180 min, and glucagon at 30, 60, 120, and 180 min. There was a significant time (p < 0.0001) but not meal composition (p = 0.14) or time by meal composition interaction (p = 0.83) effect on blood glucose.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.